BAY 38-7271 Chemical Powder
BAY 38-7271 Chemical Powder – Originally synthesized by chemist Wayne E. Kenney, BAY 38-7271 (KN 38-7271) is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotective effects and is used in scientific research. Thus proposed uses in the treatment of traumatic brain injury.
Also has analgesic and neuroprotective effects and best used in scientific research, with proposed uses in the treatment of traumatic brain injury. A full agonist with around the same potency as CP 55,940 in animal studies, and has fairly high affinity for both CB1 and CB2 receptors, with Ki values of 2.91nM at CB1 and 4.24nM at CB2. It has been licensed to KeyNeurotek Pharmaceuticals for clinical development, and is currently in Phase II trials.But its development appears has stopped.
Purity: 99,7% min
Molecular weight: 311.461
Appearance: Need to clarify
BAY 38-7271 has pain relieving and neuroprotective impacts and utilized in logical research, with proposed utilizes in the treatment of horrible mind damage. It is a full agonist with around a similar strength as CP 55,940 in creature contemplates. Also has genuinely high partiality for both CB1 and CB2 receptors. Thus with Ki estimations of 2.91nM at CB1 and 4.24nM at CB2. It has been authorized to KeyNeurotek Pharmaceuticals for clinical advancement, and is right now in Phase II trials.